MORF4 Antibody

What is MORF4 and why is it significant in cellular research?

MORF4 (mortality factor on human chromosome 4) is a cellular senescence inducing gene that causes immortal cells to stop dividing. MORF4 protein contains critical structural motifs including a nuclear localization signal (NLS), helix-loop-helix (HLH), and leucine zipper (LZ) regions, which are commonly found in transcriptional regulators . The current hypothesis suggests that MORF4 modulates the expression of key genes to induce the senescent phenotype . This makes MORF4 particularly valuable in aging research and cancer studies, where cellular senescence pathways are often dysregulated.

MORF4 is a member of a gene family that includes MRG15 (MORF4 related gene on chromosome 15) and MRGX (MORF4 related gene on chromosome X). Interestingly, MORF4 is essentially a truncated version of these proteins with over 90% identity at the amino acid level, yet only MORF4 has the ability to induce senescence in tumor cells . Understanding MORF4's unique functions requires specialized antibodies that can distinguish it from other family members despite their high sequence similarity.

RNA expression levels of MORF4 are very low in all cell types analyzed, making detection challenging even with high-quality antibodies . This low expression is likely related to its potent biological effects, as even minimal overexpression can be toxic to cells.

What applications are validated for commercial MORF4 antibodies?

Commercial MORF4 antibodies, such as the rabbit polyclonal antibody (A47919), have been validated for several key applications in molecular and cellular biology research. These applications include Western blotting (WB), immunohistochemistry (IHC), and ELISA (E) . Each application provides different insights into MORF4 biology.

For Western blotting, MORF4 antibodies have been validated using K562 cell lysates at concentrations of 1-2 μg/mL . The Western blot analysis reveals specific bands corresponding to MORF4 protein, allowing researchers to quantify expression levels across different experimental conditions. This technique is particularly valuable when studying MORF4 protein stability and degradation mechanisms.

In immunohistochemistry applications, MORF4 antibodies have been successfully used at concentrations of approximately 5 μg/mL to detect the protein in human brain tissue samples . This application enables researchers to visualize the spatial distribution of MORF4 within tissues and specific cell types, providing insights into its physiological roles.

How does MORF4 relate to MORF4L1 and other family members?

MORF4 belongs to a protein family that includes MORF4L1 (Mortality factor 4-like 1) and other MRG (MORF4-related gene) proteins. While sharing significant sequence homology, these proteins exhibit distinct functional properties. MORF4L1 is a member of histone acetyltransferase complexes and belongs to the MORF4 class of proteins, suggesting roles in chromatin modification and gene regulation .

An important distinction is that while MORF4 can induce senescence in tumor cells, MRG15 and MRGX do not possess this ability . This functional difference persists despite the high sequence similarity (over 90% identity at the amino acid level), indicating that small structural variations critically determine functional outcomes. Research shows that family members share many common interacting protein partners and are present in multiple nuclear protein complexes .

Recent studies indicate that MORF4L1 expression is decreased in several cancers, including nasopharyngeal carcinoma (NPC), suggesting potential tumor suppressor activity . The promoter of MORF4L1 shows significantly higher methylation rates in tumor cells compared to normal cells, indicating epigenetic regulation of this gene family . This differential expression pattern may provide valuable insights into the functional relationships between MORF4 and its family members in normal physiology and disease states.

What are the optimal storage and handling conditions for MORF4 antibodies?

MORF4 antibodies require specific storage and handling conditions to maintain their activity and specificity. Commercial antibodies such as the rabbit polyclonal Anti-MORF4 Antibody (A47919) should be stored at -20°C, where they typically remain stable for approximately one year . Researchers must avoid repeated freeze-thaw cycles as these can significantly degrade antibody quality and reduce binding efficiency .

Best practices for MORF4 antibody handling include aliquoting the stock solution into smaller volumes upon initial thawing to minimize freeze-thaw cycles. When working with the antibody, it's essential to avoid prolonged exposure to high temperatures as this can compromise antibody integrity . The antibody formulation typically includes 0.02% sodium azide as a preservative, which helps maintain stability but requires appropriate safety precautions during handling due to its toxicity .

For long-term experiments, researchers should validate antibody activity periodically using positive controls such as K562 cell lysates or human brain tissue sections, which have been confirmed to express detectable levels of MORF4 . This validation ensures experimental reliability and helps distinguish true negative results from those caused by antibody degradation.

Why is MORF4 protein detection challenging in experimental systems?

Detection of MORF4 protein presents several significant challenges that researchers must address through specialized experimental approaches. The primary difficulty stems from MORF4's remarkable instability—it is rapidly degraded by the ubiquitin-proteasome pathway in cells . Experiments using cycloheximide (CHX), an inhibitor of translation, have demonstrated that MORF4 protein levels significantly decrease after just 30 minutes of treatment, and become undetectable after 1 hour . This extremely short half-life necessitates specialized approaches for successful detection.

Additionally, RNA expression levels of MORF4 are naturally very low in all cell types analyzed, resulting in minimal protein production even under normal conditions . This low expression likely reflects the potent biological activity of MORF4, as even modest overexpression of this protein is toxic to cells . Researchers attempting to study MORF4 function through overexpression systems have encountered significant cytotoxicity, forcing the development of inducible expression systems to control protein levels precisely .

To overcome these challenges, researchers have successfully used proteasome inhibitors such as MG132 and Epoxomicin to stabilize MORF4 protein. Treatment with MG132 results in rapid accumulation of MORF4, with protein levels peaking at approximately 2 hours post-treatment at concentrations of 2.5 μM . This approach provides a valuable window for studying MORF4 protein interactions and functions.

What considerations are important for epitope selection in MORF4 experiments?

The selection of appropriate epitopes for MORF4 detection is critical for experimental success. Researchers must consider the cellular location of their target epitope, as this will determine necessary sample preparation techniques. MORF4 contains several important structural domains, including nuclear localization signals (NLS), helix-loop-helix (HLH), and leucine zipper (LZ) regions . Antibodies targeting different epitopes may yield varying results depending on protein conformation and interactions.

For intracellular epitopes, which include most MORF4 structural domains, proper fixation and permeabilization are essential to allow antibody access . Since MORF4 functions as a transcriptional regulator, it is primarily localized in the nucleus, requiring permeabilization protocols that effectively penetrate both cell and nuclear membranes . The specific permeabilization method should be optimized based on the cellular compartment being targeted.

The commercially available Anti-MORF4 Antibody (A47919) is raised against an 18 amino acid peptide from near the amino terminus of human MORF4 . This N-terminal targeting approach offers advantages for MORF4 detection because this region contains sequence differences that distinguish MORF4 from its family members MRG15 and MRGX . Understanding the specific epitope recognized by the antibody is essential when interpreting experimental results and designing proper controls.

How can inducible expression systems facilitate MORF4 research?

Due to MORF4's toxicity when constitutively overexpressed, inducible expression systems represent a critical tool for studying its function. Researchers have successfully employed tetracycline-inducible systems to express MORF4 in a controlled manner . This approach allows for dose-dependent and temporal control of MORF4 expression, enabling the study of its effects without immediate cellular toxicity.

A validated approach involves the use of the pLIB-rtTA-M2-TRSID-puro retroviral system, which encodes both a transcriptional repressor (TRSID) and a tetracycline-responsive activator (rtetTA-M2) . This dual-control system ensures minimal leakage expression in the uninduced state while allowing robust expression upon addition of doxycycline (dox). In experimental systems, maximum MORF4 expression is typically achieved at doxycycline concentrations between 0.5-1 μg/ml .

With this system, researchers can conduct long-term experiments such as colony size distribution (CSD) assays to assess MORF4's impact on cell proliferation and senescence induction. Studies using this approach have demonstrated that doxycycline-induced MORF4 expression significantly increases the proportion of non-dividing colonies in HeLa cells after two weeks of culture, confirming MORF4's role in senescence induction . This controlled expression approach allows for detailed kinetic studies of senescence initiation and progression that would be impossible with constitutive expression systems.

What techniques can be applied to study MORF4 protein degradation mechanisms?

The rapid degradation of MORF4 through the ubiquitin-proteasome pathway presents both challenges and research opportunities. Several complementary techniques have been validated for investigating this process. Cycloheximide chase assays represent a powerful approach for measuring MORF4 protein half-life . By inhibiting new protein synthesis with cycloheximide and monitoring protein levels over time, researchers have demonstrated that MORF4 has an exceptionally short half-life of less than one hour .

To confirm the involvement of the ubiquitin-proteasome pathway, researchers have successfully employed multiple proteasome inhibitors, including MG132 and Epoxomicin . These compounds effectively stabilize MORF4 protein, allowing for its accumulation and subsequent analysis. Additionally, UBEI-41 (also known as PYR-41), a specific inhibitor of the E1 ubiquitin-activating enzyme that acts at the first step of ubiquitination, also effectively stabilizes MORF4 protein at concentrations of 25 μM (which inhibits approximately 85% of E1 activity) .

For direct detection of MORF4 ubiquitination, co-transfection experiments with HA-tagged ubiquitin (HA-Ub) constructs followed by immunoprecipitation have been employed . This approach allows for the visualization of ubiquitinated MORF4 species through Western blotting, providing insights into the ubiquitination patterns and potentially the lysine residues targeted for modification.

How can researchers optimize Western blot protocols for MORF4 detection?

Sample preparation plays a critical role in successful MORF4 detection. Pre-treatment of cells with proteasome inhibitors like MG132 (2.5 μM for 2 hours) significantly enhances MORF4 stability and detection . Lysate preparation should include protease inhibitors, and samples should be processed rapidly at cold temperatures to minimize degradation. Additionally, researchers should consider using phosphatase inhibitors if studying potential phosphorylation-dependent regulation of MORF4.

Optimization of transfer conditions is also important, as inefficient transfer can result in poor detection of low-abundance proteins like MORF4. Using PVDF membranes rather than nitrocellulose may improve sensitivity for MORF4 detection. Finally, employing enhanced chemiluminescence (ECL) detection systems with extended exposure times may be necessary to visualize weak MORF4 signals. Including appropriate positive controls (such as K562 cell lysates) and molecular weight markers is essential for accurate interpretation of results .

What cellular assays can effectively measure MORF4-induced senescence?

Several validated cellular assays enable quantitative assessment of MORF4's senescence-inducing activity. The colony size distribution (CSD) assay represents a powerful approach for evaluating MORF4's impact on cell proliferation and senescence induction . In this assay, cells are plated at low density, treated with inducers of MORF4 expression, and allowed to form colonies over approximately two weeks. The resulting colonies are then fixed, stained, and analyzed for size distribution .

Researchers have observed that doxycycline-induced MORF4 expression significantly alters colony size profiles in HeLa cells, with a marked increase in the proportion of small, non-dividing colonies compared to untreated controls . This shift in colony size distribution directly reflects MORF4's ability to induce cellular senescence and growth arrest. The advantage of this assay is that it provides a population-level view of cellular responses while still allowing assessment of clonal variability.

Complementary approaches include measuring established senescence markers following MORF4 induction. Senescence-associated β-galactosidase (SA-β-gal) activity, p21 and p16 expression levels, heterochromatin formation, and senescence-associated secretory phenotype (SASP) markers can all be assessed to comprehensively characterize MORF4-induced senescence. These assays provide mechanistic insights into how MORF4 triggers the senescence program in cells.

How can researchers investigate MORF4's role in transcriptional regulation?

Given MORF4's structural features (NLS, HLH, and LZ domains) and hypothesized function as a transcriptional regulator, several approaches can elucidate its role in gene expression control . Chromatin immunoprecipitation (ChIP) assays can identify genomic regions directly bound by MORF4. For this application, researchers should use anti-MORF4 antibodies validated for immunoprecipitation and consider treating cells with proteasome inhibitors before fixation to stabilize MORF4 protein levels.

RNA sequencing (RNA-seq) analysis following controlled MORF4 induction provides comprehensive insights into MORF4-regulated gene expression programs. By comparing transcriptome profiles before and after MORF4 induction, researchers can identify direct and indirect target genes. This approach has revealed that MORF4 modulates the expression of key genes involved in the senescence phenotype . Time-course experiments can further distinguish primary from secondary transcriptional responses.

Co-immunoprecipitation studies have demonstrated that MORF4 family members share many common interacting protein partners and are present in multiple nuclear protein complexes . Similar approaches can identify MORF4-specific interaction partners that may explain its unique senescence-inducing ability compared to MRG15 and MRGX. Mass spectrometry analysis of immunoprecipitated complexes can provide an unbiased view of the MORF4 interactome.

What comparative approaches can distinguish MORF4 from related family proteins?

Distinguishing MORF4 from its closely related family members (particularly MRG15 and MRGX) requires careful experimental design due to their high sequence similarity (>90% at the amino acid level) . Antibody selection is critical—researchers should verify that their anti-MORF4 antibodies specifically recognize MORF4 without cross-reactivity to MRG15 or MRGX. The antibody raised against an 18 amino acid peptide from the amino terminus of human MORF4 provides specificity due to sequence differences in this region .

Functional comparisons between MORF4 and its family members reveal striking differences despite their sequence similarity. While MORF4 expression induces senescence in tumor cells, MRG15 and MRGX lack this ability . Comparative analysis of protein stability also reveals important differences—MORF4 is rapidly degraded by the ubiquitin-proteasome pathway, whereas endogenous MRG15 protein levels are not affected by proteasome inhibitor treatment . This differential stability may be attributed to structural differences, particularly the additional N-terminal sequence in MRG15 that may protect it from degradation.

Domain-swapping experiments between MORF4 and its family members can identify regions responsible for their functional differences. By creating chimeric proteins that combine domains from MORF4 with those from MRG15 or MRGX, researchers can determine which structural elements confer senescence-inducing activity, protein instability, or specific protein-protein interactions. These approaches provide mechanistic insights into how minor sequence variations translate into profound functional differences.

What protocol modifications enhance MORF4 detection in tissue samples?

Antigen retrieval represents a critical step for exposing MORF4 epitopes that may be masked during fixation. Heat-induced epitope retrieval using citrate buffer (pH 6.0) or EDTA buffer (pH 9.0) can be evaluated to determine which method provides optimal staining with minimal background. The retrieval duration and temperature should be carefully optimized for each tissue type.

Due to MORF4's rapid degradation in cellular systems, tissue processing methods that minimize the time between tissue collection and fixation are essential for preserving MORF4 signal . Researchers should consider using sections from flash-frozen tissues or perfusion-fixed specimens to maximize antigen preservation. Additionally, the use of protease inhibitors during tissue processing may help preserve MORF4 protein integrity.

How can researchers validate MORF4 antibody specificity in tissues?

Validating MORF4 antibody specificity in tissue samples is essential for accurate interpretation of immunohistochemistry results. Multiple control approaches should be implemented to ensure reliable detection. Positive controls include human brain tissue, which has been validated for MORF4 expression . Negative controls should include both omission of primary antibody and, ideally, tissues from MORF4 knockout models if available.

To address potential cross-reactivity with family members MRG15 and MRGX, researchers can perform peptide competition assays. By pre-incubating the antibody with the immunizing peptide (the 18 amino acid peptide from the amino terminus of human MORF4), specific staining should be blocked while any non-specific staining would remain . This approach helps distinguish true MORF4 signal from cross-reactivity or background.

Dual labeling with antibodies against known nuclear markers can confirm the expected nuclear localization of MORF4 and provide additional validation of staining specificity. Co-localization analysis with markers of nuclear compartments can also provide insights into MORF4's subnuclear distribution and potential functional associations.

What insights can MORF4 immunohistochemistry provide about tissue-specific expression?

Immunohistochemical analysis of MORF4 expression across different tissues and cell types can reveal important insights into its physiological roles and potential involvement in disease processes. While MORF4 RNA levels are generally low across cell types, protein expression patterns may show tissue-specific variations . Brain tissue has been validated for MORF4 expression, suggesting potential roles in neural function or brain development .

In cancer research, comparing MORF4 expression between normal and malignant tissues may reveal alterations associated with disease progression. The related protein MORF4L1 shows decreased expression in several cancers, including nasopharyngeal carcinoma, with promoter methylation significantly higher in tumor cells than normal cells . Similar epigenetic regulation might affect MORF4 expression in cancer, potentially contributing to evasion of senescence mechanisms.

Developmental studies using immunohistochemistry for MORF4 across different embryonic stages could provide insights into its roles in growth, differentiation, and tissue patterning. Age-related changes in MORF4 expression might also be relevant given its role in cellular senescence, potentially linking it to aging processes and age-related diseases.